Anti-Nivolumab Polyclonal Antibody

Product Specifications

Background

Nivolumab (Opdivo) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Nivolumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells. Antibodysystem Anti-Nivolumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Nivolumab.

Host

Rabbit

Immunogen

Nivolumab

Target

Rabbit polyclonal to Opdivo.

Clonality

Polyclonal

Applications

ELISA

Purification

Purified by antigen affinity column.

Form

Liquid

Buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Storage Conditions

The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles.

Notes

Antibodysystem can customize this product per customer's request including product size, buffer components, etc. For research use only.

Specificity

The product is specific for Nivolumab. This antibody serves as an excellent positive control for Nivolumab immunogenicity (ADA) assays.

Isotype

IgG

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

37506026 500 ng

PPPDE2 Protein Vector (Rat) (pPM-C-HA)

Ask

View Details

02293 00100 100 g

Semicarbazide Hydrochloride 98% For Synthesis

Ask

View Details

TA506541AM 100 µL

Tyrosine Hydroxylase (TH) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1A10]

Ask

View Details

248967-ML490 100 µL

MST1 (Macrophage Stimulating 1 (Hepatocyte Growth Factor-like), D3F15S2, DNF15S2, HGFL, MSP, NF15S2) (MaxLight 490)

Ask

View Details

63450051 250 µL

p27 Adenovirus (Human)

Ask

View Details